Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

被引:65
|
作者
Penack, Olaf [1 ]
Becker, Carolin [2 ]
Buchheidt, Dieter [3 ]
Christopeit, Maximilian [4 ]
Kiehl, Michael [5 ]
von Lilienfeld-Toal, Marie [6 ]
Hentrich, Marcus [7 ]
Reinwald, Marc [3 ]
Salwender, Hans [8 ]
Schalk, Enrico [9 ]
Schmidt-Hieber, Martin [10 ]
Weber, Thomas [4 ]
Ostermann, Helmut [11 ]
机构
[1] Charite Campus Virchow Klinikum, Dept Hematol Oncol & Tumourimmunol, D-13353 Berlin, Germany
[2] Rhein Westfal TH Aachen, Fac Med, Dept Oncol Hematol & Stem Cell Transplantat, Aachen, Germany
[3] Heidelberg Univ, Dept Internal Med, Univ Med Ctr Mannheim, Heidelberg, Germany
[4] Univ Hosp Martin Luther Univ, Halle, Saale, Germany
[5] Klinikum Frankfurt Oder, Dept Hematol & Oncol, Frankfurt, Germany
[6] Univ Jena, Dept Hematol & Oncol, Jena, Germany
[7] Harlaching Hosp, Dept Hematol Oncol & Palliat Care, Munich, Germany
[8] Asklepios Hosp Altona, Dept Hematol & Oncol, Hamburg, Germany
[9] Univ Magdeburg, Med Ctr, Dept Hematol & Oncol, D-39106 Magdeburg, Germany
[10] HELIOS Clin Berlin Buch, Clin Hematol Oncol & Tumourimmunol, Berlin, Germany
[11] Univ Munich, Dept Internal Med 3, Munich, Germany
关键词
Guideline; Sepsis; Neutropenia; Management; CRITICALLY-ILL PATIENTS; RENAL-REPLACEMENT THERAPY; INTENSIVE INSULIN THERAPY; BLOOD-STREAM INFECTIONS; ACUTE RESPIRATORY-FAILURE; HIGH-DOSE ANTITHROMBIN; EXTRACORPOREAL MEMBRANE-OXYGENATION; AMINOGLYCOSIDE COMBINATION THERAPY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; HUMAN SOLUBLE THROMBOMODULIN;
D O I
10.1007/s00277-014-2086-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis.
引用
收藏
页码:1083 / 1095
页数:13
相关论文
共 50 条
  • [41] Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
    Annika Y. Classen
    Larissa Henze
    Marie von Lilienfeld-Toal
    Georg Maschmeyer
    Michael Sandherr
    Luisa Durán Graeff
    Nael Alakel
    Maximilian Christopeit
    Stefan W. Krause
    Karin Mayer
    Silke Neumann
    Oliver A. Cornely
    Olaf Penack
    Florian Weißinger
    Hans-Heinrich Wolf
    Jörg Janne Vehreschild
    Annals of Hematology, 2021, 100 : 1603 - 1620
  • [42] CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
    Schmidt-Hieber, M.
    Silling, G.
    Schalk, E.
    Heinz, W.
    Panse, J.
    Penack, O.
    Christopeit, M.
    Buchheidt, D.
    Meyding-Lamade, U.
    Haehnel, S.
    Wolf, H. H.
    Ruhnke, M.
    Schwartz, S.
    Maschmeyer, G.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1207 - 1225
  • [43] Central venous catheter-related infections in hematology and oncologyGuidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Hans-Heinrich Wolf
    Malte Leithäuser
    Georg Maschmeyer
    Hans Salwender
    Ulrike Klein
    Iris Chaberny
    Florian Weissinger
    Dieter Buchheidt
    Markus Ruhnke
    Gerlinde Egerer
    Oliver Cornely
    Gerd Fätkenheuer
    Sabine Mousset
    Annals of Hematology, 2008, 87 : 863 - 876
  • [44] Treatment of invasive fungal infections in cancer patients-Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Boehme, Angelika
    Ruhnke, Markus
    Buchheidt, Dieter
    Cornely, Oliver A.
    Einsele, Herrmann
    Enzensberger, Ruxandra
    Hebart, Holger
    Heinz, Werner
    Junghanss, Christian
    Karthaus, Meinolf
    Kruger, William
    Krug, Utz
    Kubin, Thomas
    Penack, Olaf
    Reichert, Dietmar
    Reuter, Stefan
    Silling, Gerda
    Sudhoff, Thomas
    Ullmann, Andrew J.
    Maschmeyer, Georg
    ANNALS OF HEMATOLOGY, 2009, 88 (02) : CP6 - 110
  • [45] Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Ruhnke, Markus
    Cornely, Oliver A.
    Schmidt-Hieber, Martin
    Alakel, Nael
    Boell, Boris
    Buchheidt, Dieter
    Christopeit, Maximilian
    Hasenkamp, Justin
    Heinz, Werner J.
    Hentrich, Marcus
    Karthaus, Meinolf
    Koldehoff, Michael
    Maschmeyer, Grorg
    Panse, Jens
    Penack, Olaf
    Schleicher, Jan
    Teschner, Daniel
    Ullmann, Andrew John
    Vehreschild, Maria
    von Lilienfeld-Toal, Marie
    Weissinger, Florian
    Schwartz, Stefan
    MYCOSES, 2020, 63 (07) : 653 - 682
  • [46] Infectious complications after allogeneic stem cell transplantation:: epidemiology and interventional therapy strategies -: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Einsele, H
    Bertz, H
    Beyer, J
    Kiehl, MG
    Runde, V
    Kolb, HJ
    Holler, E
    Beck, R
    Schwerdfeger, R
    Schumacher, U
    Hebart, H
    Martin, H
    Kienast, J
    Ullmann, AJ
    Maschmeyer, G
    Krüger, W
    Niederwieser, D
    Link, H
    Schmidt, CA
    Oettle, H
    Klingebiel, T
    ANNALS OF HEMATOLOGY, 2003, 82 (Suppl 2) : S175 - S185
  • [47] Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumorsGuidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Oliver A. Cornely
    Angelika Böhme
    Dieter Buchheidt
    Axel Glasmacher
    Christoph Kahl
    Meinolf Karthaus
    Winfried Kern
    William Krüger
    Georg Maschmeyer
    Jörg Ritter
    Hans J. Salwender
    Michael Sandherr
    Xaver Schiel
    Silke Schüttrumpf
    Michal Sieniawski
    Gerda Silling
    Andrew J. Ullmann
    Hans-Heinrich Wolf
    Annals of Hematology, 2003, 82 : S186 - S200
  • [48] Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
    Neumann, S.
    Krause, S. W.
    Maschmeyer, G.
    Schiel, X.
    von Lilienfeld-Toal, M.
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 433 - 442
  • [49] Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
    Maschmeyer, Georg
    Beinert, Thomas
    Buchheidt, Dieter
    Cornely, Oliver A.
    Einsele, Hermann
    Heinz, Werner
    Heussel, Claus Peter
    Kahl, Christoph
    Kiehl, Michael
    Lorenz, Joachim
    Hof, Herbert
    Mattiuzzi, Gloria
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) : 2462 - 2472
  • [50] Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
    Giesen, Nicola
    Sprute, Rosanne
    Ruthrich, Maria
    Khodamoradi, Yascha
    Mellinghoff, Sibylle C.
    Beutel, Gernot
    Lueck, Catherina
    Koldehoff, Michael
    Hentrich, Marcus
    Sandherr, Michael
    von Bergwelt-Baildon, Michael
    Wolf, Hans-Heinrich
    Hirsch, Hans H.
    Wormann, Bernhard
    Cornely, Oliver A.
    Koehler, Philipp
    Schalk, Enrico
    Von Lilienfeld-Toal, Marie
    EUROPEAN JOURNAL OF CANCER, 2020, 140 : 86 - 104